High Concentration or Combined Treatment of Antisense Oligonucleotides for Spinal Muscular Atrophy Perturbed SMN2 Splicing in Patient Fibroblasts
Spinal muscular atrophy (SMA) is caused by survival motor neuron 1 SMN1 deletion. The survival motor neuron 2 (SMN2) encodes the same protein as SMN1 does, but it has a splicing defect of exon 7. Some antisense oligonucleotides (ASOs) have been proven to correct this defect. One of these, nusinersen...
Main Authors: | Wijaya, Yogik Onky Silvana, Niba, Emma Tabe Eko, Nishio, Hisahide, Okamoto, Kentaro, Awano, Hiroyuki, Saito, Toshio, Takeshima, Yasuhiro, Shinohara, Masakazu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI
2022
|
Subjects: | |
Online Access: | https://repository.ugm.ac.id/279049/1/High-Concentration-or-Combined-Treatment-of-Antisense-Oligonucleotides-for-Spinal-Muscular-Atrophy-Perturbed-SMN2-Splicing-in-Patient-FibroblastsGenes.pdf |
Similar Items
-
Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular Atrophy
by: Niba, Emma Tabe Eko, et al.
Published: (2022) -
Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular Atrophy
by: Niba, Emma Tabe Eko, et al.
Published: (2022) -
DBS Screening for Glycogen Storage Disease Type 1a: Detection of c.648G>T Mutation in <i>G6PC</i> by Combination of Modified Competitive Oligonucleotide Priming-PCR and Melting Curve Analysis
by: Emma Tabe Eko Niba, et al.
Published: (2021-11-01) -
Assessment of Spinal Muscular Atrophy Carrier Status by Determining <i>SMN1</i> Copy Number Using Dried Blood Spots
by: Yogik Onky Silvana Wijaya, et al.
Published: (2020-05-01) -
Spinal Muscular Atrophy: Diagnosis, Incidence, and Newborn Screening in Japan
by: Tomokazu Kimizu, et al.
Published: (2021-07-01)